Catalog No.
RHF45502
Species reactivity
Human, Mouse, Rat
Host species
Rabbit
Isotype
IgG
Clonality
Monoclonal
Tested applications
IF: 1:50-1:200, IHC: 1:100-1:200, IP: 1:20-1:50, WB: 1:1000-1:2000
Target
Hsp10, EPF, Early-pregnancy factor, HSPE1, 10 kDa heat shock protein, mitochondrial, CPN10, Chaperonin 10, 10 kDa chaperonin
Concentration
1 mg/ml
Endotoxin level
Please contact with the lab for this information.
Purity
>95% by SDS-PAGE.
Purification
Protein A/G purified from cell culture supernatant.
Accession
P61604
Applications
IF, IHC, IP, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.
Clone ID
R2A10
Platelet Indices and RDW to Assess Inflammatory Milieu in Subclinical Hashimoto's Thyroiditis., PMID:40528863
Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis., PMID:40527893
Exploratory digital outcome measures of motor sign progression in Parkinson's disease patients treated with prasinezumab., PMID:40523921
Interfering heterophile antibodies as the cause of persistently falsely elevated high-sensitivity troponin I on Alinity i: a case report., PMID:40520654
Doubling multiplexed imaging capability via spatial expression pattern-guided protein pairing and computational unmixing., PMID:40517167
Combined TNF-α and OX40L targeting as a new treatment option for hidradenitis suppurativa., PMID:40502542
T and B cell responses against Epstein-Barr virus in primary sclerosing cholangitis., PMID:40500415
Seroprevalence of Toxoplasmosis and the Possible Role of C-Reactive Protein in the Pathogenesis of Myocardial Infarction in Patients from Iraq; A Case Control Study., PMID:40498362
Comorbidities Are Associated With Unfavorable Outcome in Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorders and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Exploratory Study From the CROCTINO Cohort., PMID:40485599
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy., PMID:40472844
Activation of Kir4.1 Channels by 2-D08 Promotes Myelin Repair in Multiple Sclerosis., PMID:40470772
HS-10375, a selective EGFR C797S tyrosine kinase inhibitor, in advanced non-small cell lung cancer., PMID:40468352
Cost-Consequences of Cladribine Tablets for the Treatment of Highly Active Relapsing-Remitting Multiple Sclerosis in Italy., PMID:40461934
An unbiased tissue transcriptome analysis identifies potential markers for skin phenotypes and therapeutic responses in atopic dermatitis., PMID:40456762
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors., PMID:40447351
Solution structure and synaptic analyses reveal determinants of bispecific T cell engager potency., PMID:40445758
Cardio-Renal and Systemic Effects of SGLT2i Dapagliflozin on Short-Term Anthracycline and HER-2-Blocking Agent Therapy-Induced Cardiotoxicity., PMID:40427493
AdvanTIG-202: Phase 2 open-label, two-cohort multicenter study of ociperlimab plus tislelizumab and tislelizumab alone in patients with previously treated recurrent or metastatic cervical cancer., PMID:40411966
The 4 functional segments of Factor H: Role in physiological target recognition and contribution to disease., PMID:40356067
A novel cross-validated machine learning based Alertix-Cancer Risk Index for early detection of canine malignancies., PMID:40351765
Patient-reported outcomes from DESTINY-Breast04: trastuzumab deruxtecan versus physician's choice of chemotherapy in patients with HER2-low mBC., PMID:40349139
Long Covid Symptom Clusters, Correlates and Predictors in a Highly Vaccinated Australian Population in 2023., PMID:40342248
Flow Cytometry-Based Rapid Assay for Antigen Specific Antibody Relative Affinity in SRBC-Immunized Mouse Models., PMID:40332147
Cohort profile: the Swedish Inception Cohort in inflammatory bowel disease (SIC-IBD)., PMID:40328654
Performance of cryptogenic new onset refractory status epilepticus score in a Brazilian cohort after testing for antineuronal antibodies with tissue-based and cell-based assays., PMID:40318023
Comparative analysis of replication and immune evasion among SARS-CoV-2 subvariants BA.2.86, JN.1, KP.2, and KP.3., PMID:40298448
Assessing the clinical progress of the bispecific nanobody sonelokimab., PMID:40297934
Nivolumab and stereotactic radiosurgery for patients with breast cancer brain metastases: long-term results and biomarker analysis from a non-randomized, open-label, phase Ib study., PMID:40295143
Ephrin-B1 regulates cell surface residency of heparan sulfate proteoglycans (HSPGs) and complexes with the HSPG CD44V3-10 and fibroblast growth factor receptors., PMID:40294072
Feasibility and Tolerability of Subcutaneous Immunoglobulin via Manual Push Pre-Filled Syringes for Inflammatory Neuropathies: A Retrospective Cohort Study., PMID:40289538
Engineered ACE2 decoy in dry powder form for inhalation: A novel therapy for SARS-CoV-2 variants., PMID:40276779
A neutralizing nanobody-based liquid-phase blocking ELISA to assess the protective potency of Senecavirus A vaccine., PMID:40266308
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy., PMID:40255392
Exploration of IgE Specific to Staphylococcal Serine Protease-Like Protein A as a Phenotypic Marker in Late-Onset Asthma., PMID:40249510
Lenalidomide in combination with rituximab, dexamethasone, high-dose ARA-C and cisplatinum as salvage therapy in refractory or relapsed aggressive B-cell non-hodgkin-lymphoma - an open-label, multicentre phase I/II study (DSHNHL-R6)., PMID:40232406
Effectiveness and safety of the four-step versus six-step milk ladder in children with IgE-mediated cow's milk protein allergy: protocol for an open-label randomised controlled trial., PMID:40228856
CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemia., PMID:40213559
Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study., PMID:40209615
Safety and implementation of phase I randomized GLA-SE-adjuvanted CH505TF gp120 HIV vaccine trial in newborns., PMID:40178906
Bifidobacteria support optimal infant vaccine responses., PMID:40175554
TIMEPOINT, a phase 1 study combining MTL-CEBPA with pembrolizumab, supports the immunomodulatory effect of MTL-CEBPA in solid tumors., PMID:40168999
Effectiveness of Switching From Upadacitinib to Tralokinumab in Patients With Moderate-to-Severe Atopic Dermatitis: A Real-World Clinical Practice., PMID:40165566
Increased immunogen valency improves the maturation of vaccine-elicited HIV-1 VRC01-class antibodies., PMID:40161829
RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques., PMID:40159504
IgM has a better relative distribution in inflammation sites and tumor tissues than IgG., PMID:40156022
Development and optimization of human T-cell leukemia virus-specific antibody-dependent cell-mediated cytotoxicity (ADCC) assay directed to the envelope protein., PMID:40152593
Opportunities and Challenges in Antibody-Drug Conjugates for Cancer Therapy: A New Era for Cancer Treatment., PMID:40149295
Imaging oligomers of alpha-toxin (Hla) variants using high-speed AFM and neutralizing Hla hemolytic activity with their antisera., PMID:40147500
rVSVΔG-ZEBOV-GP Vaccine Is Highly Immunogenic and Efficacious Across a Wide Dose Range in a Nonhuman Primate EBOV Challenge Model., PMID:40143273
An mRNA vaccine against monkeypox virus inhibits infection by co-activation of humoral and cellular immune responses., PMID:40140411
For research use only. Not for human or drug use.
